The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 23, 2018

Filed:

Dec. 04, 2014
Applicant:

National Research Council of Canada, Ottawa, CA;

Inventors:

Danica Stanimirovic, Ottawa, CA;

Kristin Kemmerich, Ottawa, CA;

Arsalan S. Haqqani, Kanata, CA;

Traian Sulea, Kirkland, CA;

Mehdi Arbabi-Ghahroudi, Ottawa, CA;

Bernard Massie, Laval, CA;

Rénald Gilbert, Montréal, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 47/50 (2017.01); A61K 38/18 (2006.01); G01N 33/566 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61K 38/18 (2013.01); A61K 47/6811 (2017.08); A61K 47/6845 (2017.08); G01N 33/566 (2013.01); C07K 2317/22 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/64 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); G01N 2333/72 (2013.01);
Abstract

The blood-brain barrier (BBB) prevents transport of molecules larger than 500 Daltons from blood to brain. Receptor-mediated transcytosis (RMT) facilitates transport across the BBB of specific molecules that bind receptors on brain endothelial cells that form the BBB. An insulin-like growth factor 1 receptor (IGF1R)-binding antibody or fragment thereof is identified that transmigrates the BBB by RMT. The antibody or fragment is used to deliver a cargo molecule across the BBB, wherein the cargo molecule may be a therapeutic or detectable agent. The antibody is a camelid VHH, prepared by immunizing a llama with a 933-amino acid IGF1R polypeptide. Humanized forms of the camelid VHH are also generated.


Find Patent Forward Citations

Loading…